Puma Biotechnology to Present at Barclays Annual Global Healthcare ConferenceBusiness Wire • 03/05/25
Puma Biotechnology Reports Fourth Quarter and Full Year 2024 Financial ResultsBusiness Wire • 02/27/25
Puma Biotechnology to Present at TD Cowen's 45th Annual Health Care ConferenceBusiness Wire • 02/26/25
Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial ResultsBusiness Wire • 02/13/25
All You Need to Know About Puma Biotech (PBYI) Rating Upgrade to Strong BuyZacks Investment Research • 01/01/25
Puma Biotechnology's NERLYNX® Included in NCCN Clinical Practice Guidelines for the Treatment of Cervical Cancer with a HER2 MutationBusiness Wire • 12/23/24
Puma Biotechnology Announces Initiation of ALISCA™-Breast1 Phase II Trial of Alisertib in Hormone Receptor-Positive, HER2-Negative Metastatic Breast CancerBusiness Wire • 11/20/24
PBYI Beats Q3 Earnings & Revenue Estimates, Revises '24 View, Stock UpZacks Investment Research • 11/08/24
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Puma Biotechnology, Inc. (NASDAQ: PBYI) and Encourages Investors to Contact the FirmGlobeNewsWire • 10/29/24
Puma Biotechnology to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceBusiness Wire • 09/03/24
Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2024 Financial ResultsBusiness Wire • 07/18/24